Type 2 diabetes mellitus is associated with disruptions as a function of metabolic control. by Trento, Marina et al.
Type 2 diabetes mellitus is associated with disruptions as a function of metabolic 
control 
 
M. Trento1, F. Riganti1, M. Tomelini1, P. Passera, F. Broglio1, E. van Cauter2, M. Porta1, E. Ghigo1 
 
1Department of Internal Medicine, University of Turin, Italy; 2Department of Medicine, University of Chicago, IL, USA 
 
Background and aims Sleep disturbances may be an independent risk factor for glucose 
intolerance and, in type 2 diabetes mellitus (T2DM), sleep disruption was shown to correlate with 
metabolic control. We aimed at evaluating sleep quality in non-obese T2DM patients treated with 
oral agents and without complications. Methods Sleep recording was performed in 25 middle-aged 
T2DM patients and 18 age- and sex-matched healthy controls subjects (CS) by wrist actigraphy 
(Actiwatch, MiniMitterCo, USA) on three consecutive working days in free living conditions. Data 
were analysed using ActiwareSleepSoftware. Results There were no significant differences 
between T2DM and CS in terms of time in bed (mean±SD 7h40’±0h53’ vs 7h36’±1h06’), actual 
sleep time (6h25’±0h52’ vs 6h36’±1h03’), sleep efficiency (83.77±6.92 vs 86.81±4.19%) and sleep 
latency (11’±11’ vs 09’±07’). However, T2DM patients showed lower (p<0.05) actual sleep 
percentage (88.77±4.56 vs 91.27±3.15%), higher (p<0.01) fragmentation index (21.10±8.14 vs 
15.26±3.90), higher (p<0.05) total activity score during night-time (7822±3596 vs 6339±3672) and 
increased (p<0.01) moving time percentage (11.26±5.09 vs 7.88±1.50%). In T2DM, HbA1c 
correlated negatively with sleep efficiency (r=-0.624; p<0.01) and actual sleep percentage (r=-
0.585; p<0.01) and positively with fragmentation index (r=0.576; p<0.01), moving time percentage 
(r=0.651; p<0.01) and mean activity score during night-time (r=0.493; p<0.05). Discussion These 
data suggest that T2DM is associated with quantitative and qualitative sleep disruption which 
correlate with metabolic control, even in the absence of complications.  
 
